Literature DB >> 9137471

Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines.

J F Santibáñez1, A Navarro, J Martínez.   

Abstract

Genistein -a natural flavone compound with antitumor activity- has been proposed as an effective agent to prevent the expression of metastasic capacity in hormone-dependent cancers. The present study represents an effort to assess the efficacy of Genistein in inhibiting the proliferation and expression of the in vitro invasive capacity of tumoral prostatic cells with different invasive potential. In a cell culture system, genistein appeared to be cytotoxic and inhibitory of miaration through a Material barrier to PC-3 cells, the more aggressive invasive cell-line studied. DU-145 and LNCaP cells, which are less invasive than PC-3, are less affected by Genistein both with respect to proliferation rate and inhibition of u-PA and 72 kDa Gelatinase secretion. Measurement of the level of tyrosine-phosphoproteins in the three cell lines studied also showed that PC-3 cells are the most sensitive cells, with a possible molecular target in a membrane-bound protein of 130 kDa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137471

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.

Authors:  Eric A Klein
Journal:  Rev Urol       Date:  2002

Review 2.  Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function.

Authors:  Elizabeth R Gilbert; Dongmin Liu
Journal:  Food Funct       Date:  2013-02       Impact factor: 5.396

Review 3.  Perspectives on the role of isoflavones in prostate cancer.

Authors:  Aamir Ahmad; Bernhard Biersack; Yiwei Li; Bin Bao; Dejuan Kong; Shadan Ali; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  AAPS J       Date:  2013-07-04       Impact factor: 4.009

4.  Characterization of chikusetsusaponin IV and V induced apoptosis in HepG2 cancer cells.

Authors:  Tian Zuo; Zuo Zhang; Peng Jiang; Rui Zhang; Danni Ni; Yuan Yuan; Shaopeng Zhang
Journal:  Mol Biol Rep       Date:  2022-02-25       Impact factor: 2.742

5.  Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.

Authors:  Yiwei Li; Mingxin Che; Sunita Bhagat; Kerrie-Lynn Ellis; Omer Kucuk; Daniel R Doerge; Judith Abrams; Michael L Cher; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

6.  3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.

Authors:  Sunyata Smith; Daniel Sepkovic; H Leon Bradlow; Karen J Auborn
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

7.  Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells.

Authors:  Cornel J Phillip; Christopher K Giardina; Birdal Bilir; David J Cutler; Yu-Heng Lai; Omer Kucuk; Carlos S Moreno
Journal:  BMC Cancer       Date:  2012-04-11       Impact factor: 4.430

Review 8.  Genistein: does it prevent or promote breast cancer?

Authors:  K B Bouker; L Hilakivi-Clarke
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

9.  Skip Regulates TGF- β 1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells.

Authors:  Victor Villar; Jelena Kocic; Juan F Santibanez
Journal:  Prostate Cancer       Date:  2013-05-20

10.  Effect of Genistein on Apoptosis and Proliferation of Hepatocellular Carcinoma Hepa1-6 Cell Line.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi; Ali Valiani; Mohamed Amin Ghobadifar
Journal:  Int J Prev Med       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.